Srikanth Venkatraman
About Srikanth Venkatraman
Srikanth Venkatraman is an accomplished medicinal chemist with over twenty years of experience, known for his work on protease inhibitors and his significant contributions to the development of HCV drugs like Victrelis and Arlansa.
SVP, Head of Chemistry
Srikanth Venkatraman holds the position of Senior Vice President and Head of Chemistry. In this role, he leads the department focused on innovative research and development in medicinal chemistry and drug discovery. His leadership encompasses both strategic oversight and practical involvement in driving forward groundbreaking projects within the organization.
Education and Expertise
Srikanth Venkatraman obtained his doctoral degree from the University of Pittsburgh, where he developed a strong foundation in medicinal chemistry. Following this, he completed his postdoctoral training at the University of Illinois at Urbana Champaign. With twenty years of research experience, his expertise lies particularly in the design of novel protease inhibitors, contributing significantly to the field of drug discovery.
Research Experience in Medicinal Chemistry
With two decades of research experience, Srikanth Venkatraman specializes in medicinal chemistry and drug discovery. His significant contributions include the design and development of novel protease inhibitors. His research focuses have had a substantial impact on the development of new therapeutic agents, particularly for challenging health conditions.
Co-inventor of Victrelis and Arlansa
During his tenure at Schering Plough, which was later acquired by Merck, Srikanth Venkatraman co-invented Victrelis and Arlansa. These first-generation HCV protease inhibitors represent critical advancements in the treatment of Hepatitis C Virus (HCV) infections. His work on these drugs exemplifies his innovative approach and scientific rigor.
Heroes of Chemistry Award
Srikanth Venkatraman received the prestigious Heroes of Chemistry award from the American Chemical Society. This award highlights his exceptional contributions to the field of chemistry, recognizing his role in the development of impactful therapeutic agents. This accolade underscores his commitment and significant achievements in medicinal chemistry and drug discovery.